Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Khankoeva, A."'
Autor:
V. V. Bartashevich, V. B. Boldin, D. V. Sirotenko, A. I. Khankoeva, P. B. Popov, P. A. Galenko-Yaroshevskii, A. V. Uvarov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 125:567-572
Antidepressant befol, non-glycoside cardiotonic suphan, and their combinations were shown to have different ability to decrease cardiotoxic (arrhythmogenic) effect of novocainamide, lidocaine, bonnecor, obsidan, cordarone, verapamil, and rhythmidazol
Autor:
A. V. Uvarov, V. V. Skibitskii, P. A. Galenko-Yaroshevskii, V. B. Boldin, M. M. Seredenko, A. I. Khankoeva
Publikováno v:
Bulletin of Experimental Biology and Medicine. 124:1189-1193
The antiarrhythmic rhythmidazol produces a cardiotoxic effect that can be corrected by suphan, befol, and their combinations, as evidenced by normalization of ultrastructural organization of cardiomyocytes and myocardial oxygen consumption by these d
Autor:
V. V. Bartashevich, A. I. Khankoeva, I. L. Cherednik, P. A. Galenko-Yaroshevskii, Yu. R. Sheikh-Zade
Publikováno v:
Bulletin of Experimental Biology and Medicine. 124:691-695
The antihistamine drugs (H1-blockers) dimebone and especially phencarol exhibit antiarrhythmic activity under conditions of neurogenic ventricular fibrillation. The antiarrhythmic activity of phencarol is associated with pronounced vagolytic effect,
Publikováno v:
Bulletin of Experimental Biology and Medicine. 126:1170-1172
Transmembrane potentials on the plasma (Δφ4) and mitochondrial (Δφm) membrane of isolated rat cardiomyocytes were estimated using the potential-sensitive fluorescent probe DSM. The values were −93±4 and −196±11 mV, respectively. Sufan signi
Autor:
Yu. P. Sheikh-Zade, A. I. Khankoeva, I. L. Cherednik, P. B. Popov, P. A. Galenko-Yaroshevskii
Publikováno v:
Scopus-Elsevier
Antiarrhythmic activity of befol in neurogenic atrial fibrillation is due to its cardiotropic and cholinolytic effects and coincides with the dynamics of the tonic component of vagal chronotropic influence. Unlike befol, sufan has no effect on the du
Publikováno v:
Bulletin of Experimental Biology and Medicine. 125:50-52
Considerable potentiation of antiarrhythmic and antifibrilation effects of two cardiotonic agents, Suphan and the Na-channel blocker L1, was found in the model experimentsin vivo with early occlusion and reperfusion arrhythmias. Suphan in combination
Publikováno v:
Bulletin of Experimental Biology and Medicine. 124:1197-1199
The effect of glucose-base polymers (dextrans with relative molecular weight 10, 40, and 70 kD) and vinylpyrrolidone (polyvinylpyrrolidone: 10, 24, and 40 kD) on changes in the sarcoplasmic Na+ concentration in stimulated cardiomyocytes (1.0 Hz, 10 m
Autor:
A. I. Khankoeva, P. A. Galenko-Yaroshevskii, I. L. Cherednik, Yu. R. Sheikh-Zade, N. B. Leonidov, D. S. Galygo, S. B. Fitilev
Publikováno v:
Scopus-Elsevier
Antiarrhythmic activities of KLN-93 (crystallographically homogeneous paraaminobenzoic acid ester derivative), dicaine, and lidocaine in cats with neurogenic atrial fibrillation rank in the order in which these agents are named and depend on their va
Publikováno v:
Bulletin of Experimental Biology and Medicine. 123:579-581
The effects of the antiarrhythmic preparations lidocaine, flecainide, and rhlocaine on sodium concentration in cardiomyocyte cytoplasm are studied using the Na-sensitive fluorescent probe SBFI. The Na-blocking effect of lidocaine and rihlocaine depen
Autor:
A. I. Khankoeva, A. V. Uvarov, A. Yu. Reznikov, V. V. Bartashevich, D. S. Galygo, P. B. Popov, P. A. Galenko-Yaroshevskii
Publikováno v:
Bulletin of Experimental Biology and Medicine. 123:474-476
It is shown that the nonglycoside cardiotonic drug suphan exhibits antiarrhythmic and antifibrillatory activity, although less pronounced than that of lidocaine. When lidocaine was administered after suphan, the antifibrillatory effects of both prepa